AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26899778
Drug: Investigator's choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigator's choice monotherapy (rituximab, gemcitabine, fludarabine, chlorambucil, or cytarabine)
Trial: 19776140
Drug: 16 g
RxNorm normalized name: Maltsupex, 16 g/15 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 g prebiotics/d
Trial: 19776140
Drug: 16 g
RxNorm normalized name: Maltsupex, 16 g/15 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 g dextrin maltose/d
Trial: 2520624
Drug: Morning dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dose of 40 mg famotidine
Trial: 2520624
Drug: Bedtime dose
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime dose of 40 mg famotidine
Trial: 2520624
Drug: Both morning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both morning and bedtime doses of famotidine
Trial: 4741605
Drug: Mestranol, average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mestranol, average daily dose of 23 mug, started within two months of operation
Trial: 4741605
Drug: Mestranol, average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mestranol, average daily dose of 23 mug, started three years after oophorectomy
Trial: 4741605
Drug: Mestranol, average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mestranol, average daily dose of 23 mug, started six years after oophorectomy
Trial: 16533356
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg/day) and zinc sulphate (66 mg/day)
Trial: 12713766
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus pravastatin (pooled doses)
Trial: 12713766
Drug: Pravastatin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin alone (pooled doses)
Trial: 10982248
Drug: rhEPO 200
RxNorm normalized name: rhTPO
DrugBank: Recombinant Human Thrombopoietin (DB16364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO 200 U/kg body weight subcutaneously twice weekly combined with iron sucrose 200 mg intravenously twice weekly
Trial: 10982248
Drug: rhEPO 200
RxNorm normalized name: rhTPO
DrugBank: Recombinant Human Thrombopoietin (DB16364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPO 200 U/kg body weight subcutaneously twice weekly combined with iron sulfate 160 mg/day orally
Trial: 29925680
Drug: Negative Pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative Pressure Treatment (NPT) applied on the sutured wound for one week postoperatively
Trial: 27255080
Drug: Medication-adherence tool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-adherence tool intervention
Trial: 27255080
Drug: Medication-adherence assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-adherence assessment (Control)
Trial: 19661244
Drug: Prednisone 30
RxNorm normalized name: prednisone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 30 mg/d
Trial: 16451406
Drug: Piperacillin-tazobactam monotherapy
RxNorm normalized name: piperacillin / tazobactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam monotherapy
Trial: 11318079
Drug: Desloratadine 5
RxNorm normalized name: desloratadine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine 5 mg once daily with azithromycin
Trial: 11318079
Drug: Fexofenadine 60
RxNorm normalized name: fexofenadine 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 60 mg twice daily with azithromycin
Trial: 2835890
Drug: Enalapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 40 mg once daily
Trial: 21044669
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of PCV-7
Trial: 21044669
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of PCV-7
Trial: 21044669
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of PCV-7
Trial: 21044669
Drug: 0 doses
RxNorm normalized name: mometasone furoate 220 mcg/actuation (30 doses) INHALATION AEROSOL POWDER, BREATH ACTIVATED (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 doses of PCV-7 (unvaccinated group)
Trial: 18789766
Drug: Interferon beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a (44 mcg subcutaneous three times per week)
Trial: 18789766
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate (20 mg subcutaneous once per day)
Trial: 29019365
Drug: Blueberry supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blueberry supplementation (22.5 g freeze-dried) twice daily for six weeks
Trial: 23506636
Drug: Carvedilol (25.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25.6 ± 12.6 mg daily)
Trial: 23506636
Drug: Bisoprolol (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (5.0 ± 2.4 mg daily)
Trial: 23506636
Drug: Nebivolol (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (5.0 ± 2.4 mg daily)
Trial: 15602250
Drug: Ice application
RxNorm normalized name: Camphor Ice Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice application before injections
Trial: 3659227
Drug: H1-antagonist dimethindene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1-antagonist dimethindene (Di) (0.1 mg/kg i.v.)
Trial: 3659227
Drug: H2-antagonist cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: H2-antagonist cimetidine (Ci) (5 mg/kg i.v.)
Trial: 3659227
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dimethindene and cimetidine (Di + Ci)
Trial: 3659227
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Ci and Di
Trial: 24001154
Drug: cilostazol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilostazol (100 mg) plus GBE (80 mg)
Trial: 24001154
Drug: cilostazol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilostazol (100 mg) plus placebo
Trial: 20934771
Drug: Propofol sedation
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol sedation (70-100 mg/procedure)
Trial: 20934771
Drug: Midazolam sedation
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam sedation (3-6 mg/procedure)
Trial: 19559158
Drug: Literature review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Literature review on treatment options for osteoporosis in IBD; specific interventions not detailed.
Trial: 15447896
Drug: Biscuit meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biscuit meal (17 g SAG/100 g)
Trial: 15447896
Drug: Flakes meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flakes meal (2 g SAG/100 g)
Trial: 9647493
Drug: Enalapril (5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5‐10 mg/day)
Trial: 9647493
Drug: Metoprolol (40‐120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (40‐120 mg/day)
Trial: 8004883
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg cinnarizine
Trial: 8004883
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg cinnarizine
Trial: 2547664
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy prior to elective surgery
Trial: 2547664
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiotherapy (comparison group)
Trial: 23125444
Drug: Ad26-EnvA vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ad26-EnvA vaccine (10(9) vp, 10(10) vp, 10(11) vp)
Trial: 23125444
Drug: Ad26-EnvA vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ad26-EnvA vaccine (10(11) vp)
Trial: 23125444
Drug: Ad26-EnvA vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ad26-EnvA vaccine (10(9), 10(10), 10(11) vp 3-dose and 10(10) and 5 × 10(10) vp 2-dose groups
Trial: 16627377
Drug: Orlistat (Xenical)
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat (Xenical) 120 mg 3 times daily
Trial: 15545095
Drug: 1540-nm Er:glass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1540-nm Er:glass laser treatment (5 treatments at 6-week intervals)
Trial: 15545095
Drug: Maintenance treatments
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatments (2 additional treatments at 14 and 20 months)
Trial: 10770196
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy (fenfluramine, 60 mg/day) with energy restriction (−700 Cal/day)
Trial: 9340029
Drug: Epidural patient-controlled
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural patient-controlled analgesia (PCEA) with bupivacaine 0.25% + sufentanil 2 micrograms/ml (bolus 0.05 ml/kg, lockout 10 min)
Trial: 9340029
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia (PCA) with morphine (bolus 2 mg, lockout 10 min)
Trial: 3979482
Drug: Intravenous naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous naloxone (2 mg)
Trial: 30045066
Drug: Cariprazine 1.0-2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 1.0-2.0 mg/day
Trial: 30045066
Drug: Cariprazine 0.1-0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 0.1-0.3 mg/day
Trial: 16149361
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone (CR oxycodone)
Trial: 9799882
Drug: Alpha tocopherol
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha tocopherol 50 mg per day
Trial: 9799882
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene 20 mg per day
Trial: 383099
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate treatment
Trial: 24612734
Drug: Axaven(®) once
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Axaven(®) once a day for 8 months as adjunctive treatment with standard treatment (compression therapy and surgical correction of superficial venous incompetence)
Trial: 24612734
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment according to clinical conditions (control group)
Trial: 25587162
Drug: Endotracheal liquid
RxNorm normalized name: ALCOHOL 80 mL in 100 mL ENDOTRACHEAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endotracheal liquid bolus (ELB) albuterol
Trial: 25587162
Drug: Metered-dose inhaler
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered-dose inhaler (MDI) albuterol
Trial: 16384948
Drug: Ruboxistaurin (RBX)
RxNorm normalized name: ethanol
DrugBank: Ruboxistaurin (DB11829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ruboxistaurin (RBX) 16 mg twice daily for 28 days
Trial: 16384948
Drug: Ruboxistaurin (RBX)
RxNorm normalized name: ethanol
DrugBank: Ruboxistaurin (DB11829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ruboxistaurin (RBX) (8 mg twice a day, 16 mg per day, or 16 mg twice a day)
Trial: 14598034
Drug: German version
RxNorm normalized name: German cockroach allergenic extract
DrugBank: Blatella germanica (DB10418)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: German version of the Structured Inventory of Malingered Symptomatology (SIMS) administered to students instructed to feign conditions
Trial: 14598034
Drug: German version
RxNorm normalized name: German cockroach allergenic extract
DrugBank: Blatella germanica (DB10418)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: German version of the Structured Inventory of Malingered Symptomatology (SIMS) administered to students responding honestly
Trial: 14598034
Drug: German version
RxNorm normalized name: German cockroach allergenic extract
DrugBank: Blatella germanica (DB10418)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: German version of the Structured Inventory of Malingered Symptomatology (SIMS) administered to sexually delinquent patients with antisocial personality disorders
Trial: 8629845
Drug: Oral tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tacrolimus (FK 506) at an initial dose of 0.05 mg/kg per day, increased to 0.10 and 0.15 mg/kg per day if necessary
Trial: 8629845
Drug: Oral tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tacrolimus (FK 506)
Trial: 1475268
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg flupirtine
Trial: 1475268
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg flupirtine
Trial: 20538704
Drug: Disease-modifying treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying treatments (DMTs)
Trial: 20538704
Drug: Symptomatic treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatments (STs)
Trial: 18923170
Drug: Monovalent type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent type 1 oral poliovirus vaccine
Trial: 18923170
Drug: Trivalent oral
RxNorm normalized name: poliovirus vaccine, live, trivalent oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent oral poliovirus vaccine
Trial: 15892276
Drug: Erigeron injection
RxNorm normalized name: ERIGERON CANADENSIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erigeron injection (EI) 40 ml/d for 15 days
Trial: 11936731
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplements for 6 weeks
Trial: 11936731
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no vitamin A supplements)
Trial: 9894936
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between vaccine and control groups
Trial: 2076677
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg chloroquine base weekly for six months
Trial: 7191229
Drug: Glycopyrrolate, 0.0045
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate, 0.0045 mg/kg IV
Trial: 7191229
Drug: Glycopyrrolate, 0.008
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate, 0.008 mg/kg IV
Trial: 7191229
Drug: Atropine, 0.009
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine, 0.009 mg/kg IV
Trial: 19142668
Drug: HA+FU infusion
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA+FU infusion group
Trial: 9734727
Drug: Aspartame (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (high dose: 45 mg x kg body wt(-1) x d(-1))
Trial: 9734727
Drug: Aspartame (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (low dose: 15 mg x kg body wt(-1) x d(-1))
Trial: 7999480
Drug: Topical analgesia
RxNorm normalized name: ANALGESIC TOP GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical analgesia
Trial: 31399381
Drug: Personalised mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalised mechanical ventilation (based on lung morphology); tidal volume of 8 mL/kg for focal ARDS, 6 mL/kg for non-focal ARDS, low PEEP, recruitment manoeuvres, and prone position.
Trial: 31399381
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received standard care; tidal volume of 6 mL/kg, low PEEP, and encouraged early prone position.
Trial: 30095773
Drug: Individualized oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized oxycodone prescription (predicted based on each patient's inpatient opioid use)
Trial: 30095773
Drug: Standard oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oxycodone prescription (30 tablets of 5 mg oxycodone)
Trial: 30095773
Drug: Individualized oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized oxycodone prescription
Trial: 30095773
Drug: Standard oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oxycodone prescription
Trial: 27159341
Drug: Plasma varenicline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma varenicline levels ≥3ng/mL
Trial: 27159341
Drug: Plasma varenicline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma varenicline levels ≥5ng/mL
Trial: 20194013
Drug: Oxytocin 5-unit
RxNorm normalized name: oxytocin 5 UNT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin 5-unit bolus and placebo infusion
Trial: 20194013
Drug: Oxytocin 5-unit
RxNorm normalized name: oxytocin 5 UNT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin 5-unit bolus and oxytocin 30-unit infusion
Trial: 17638549
Drug: Oral diclofenac
RxNorm normalized name: diclofenac Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diclofenac sodium (50 mg for body weight <70 kg; 100 mg for body weight >70 kg) 60 minutes prior to SWL
Trial: 17638549
Drug: Topical EMLA
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical EMLA (5 g) 60 minutes prior to SWL
Trial: 17638549
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral diclofenac sodium and topical EMLA (5 g) 60 minutes prior to SWL
Trial: 11061518
Drug: Standard recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard recombinant human GH therapy (0.3 mg/kg x week)
Trial: 11061518
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose recombinant human GH therapy (0.7 mg/kg x week)
Trial: 9279533
Drug: Glibenclamide 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide 10 mg
Trial: 8336373
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment (chlorthalidone, acebutolol, doxazosin mesylate, amlodipine maleate, enalapril maleate)
Trial: 8336373
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment (all drug groups combined)
Trial: 3459351
Drug: Standard gemfibrozil
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard gemfibrozil dosage of two 300-mg capsules 2 times a day (total 1200 mg daily)
Trial: 3459351
Drug: 600-mg tablet
RxNorm normalized name: ubidecarenone 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600-mg tablet of gemfibrozil 2 times a day (total 1200 mg daily)
Trial: 3459351
Drug: Two 450-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 450-mg tablets of gemfibrozil once a day in the evening
Trial: 2968669
Drug: Colchicine capsule
RxNorm normalized name: Colchicine Capsules
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colchicine capsule (burst dose regimen)
Trial: 31064666
Drug: Liquid oral
RxNorm normalized name: M-End Liquid Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid oral nutritional supplement (ONS)
Trial: 29101841
Drug: Educational Support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational Support Therapy (C)
Trial: 25933976
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate (220 mg containing 50mg zinc element) for 12 weeks
Trial: 21284697
Drug: Nicotine Patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine Patch (Nicotinell Patch 10cm(2), 17.5mg nicotine, average delivery rate 7mg/24h)
Trial: 19307503
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m² (arm A)
Trial: 19307503
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m² plus carboplatin AUC 5 (arm B)
Trial: 11134438
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron group (9 mg/kg/day of iron polymaltose complex)
Trial: 11134438
Drug: EPO +
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO + oral iron group (300 U of recombinant human EPO kg/day and daily oral IPC)